Gamasutra is part of the Informa Tech Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Gamasutra: The Art & Business of Making Gamesspacer
View All     RSS
August 7, 2020
arrowPress Releases







If you enjoy reading this site, you might also want to check out these UBM Tech sites:


 

FDA clears game to treat pediatric ADHD

by Noah Falstein on 06/17/20 10:33:00 am   Expert Blogs

The following blog post, unless otherwise noted, was written by a member of Gamasutra’s community.
The thoughts and opinions expressed are those of the writer and not Gamasutra or its parent company.

 

Eleven years ago I started working with Dr. Adam Gazzaley, a neuroscientist and brain imaging specialist at UCSF who had an idea of making a game to research the effectiveness of his attention training methods. He brought on some other ex-LucasArts developers to build it, and did fMRI and EEG testing to verify its efficacy. That became Neuroracer, the first (and so far only) game to grace the cover of the scientific journal Nature. And it grew into a company called Akili Interactive, who brought on board a bunch of game developers to create a more capable game aimed at pediatric ADHD. Yesterday we finally got this long-sought announcement from the FDA.

So now a game called EndeavorRx - not a "gamified app" or some boring therapy sequence with achievements tacked on - is cleared for marketing as a digital pharmaceutical, giving the games industry an opening into that market - annually $300 Billion in the US alone - and an approved way to use games to help people with pressing medical problems. Other areas that have shown much promise are treatment of PTSD, phobias, chronic pain, depression, and MS, as well as training for doctors and caregivers, and early detection of Parkinson's, Alzheimer's and other degenerative diseases. This is a big deal for our industry, a way for us to do a lot of good in the world. Once a new treatment gets this De Novo clearance, it speeds the process of similar approaches to get FDA sign-off.

Just a disclaimer - this is not an official Akili press release, my own role in Akili is very modest, I advise and do occasional consulting work, and I should particularly credit Matt Omernick, one of their co-founders with leading a lot of the game development efforts from the Neuroracer days onward.

 


Related Jobs

Wooga GmbH
Wooga GmbH — Berlin, Germany
[08.07.20]

Unity Game Engineer
Disbelief
Disbelief — Cambridge, Massachusetts, United States
[08.06.20]

Programmer
Wizards of the Coast
Wizards of the Coast — Renton, Washington, United States
[08.06.20]

Lead Client Engineer
The Savannah College of Art & Design
The Savannah College of Art & Design — Savannah, Georgia, United States
[08.06.20]

Chair of Visual Effects





Loading Comments

loader image